Dr. Sudharshan Elangovan is a transformational leader with over 15 years of experience in genomics, oncology, and precision medicine. He holds a Ph.D. in Translational & Molecular Medicine from Università degli Studi di Milano-Bicocca and has held key roles at organizations like Wipro Life Sciences and Humanitas University. Specializing in regulatory compliance, NGS testing, and laboratory operations, Dr. Elangovan drives impactful initiatives that bridge genomic innovations with clinical applications. His expertise in operational excellence and multidisciplinary collaboration has been instrumental in enhancing patient outcomes and advancing precision medicine.